The CDC is NOT stopping use of PCR

On 8/02/21, the CDC gave an update to the Lab Alert Issued on 7/21/21 regarding the “withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel” ( www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html), titled Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel ( www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html?ACSTrackingID=USCDC_2146-DM62994 ), which states for the reason of the change:

“consider transitioning to a test that can generate a result for both influenza and SARS-CoV-2, rather than running separate tests for each virus”

The test they recommend in its place is the “CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay”.. if you click that link you will see, “The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcription polymerase chain reaction (RT-PCR) test ( www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html)

We are primarily funded by readers. Please subscribe and donate to support us!

And as for the question, is CDC retiring the CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel because it has produced inaccurate results?, the answer they give is, No.” (see link #1)

 

h/t Make Free Speech Great Again

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.